We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
-18.91%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
-$35.7M
Cap. Flow
-$4.31M
Cap. Flow %
-3.89%
Top 10 Hldgs %
28.98%
Holding
213
New
40
Increased
55
Reduced
31
Closed
62

Top Buys

Rank Stock Value
1
BCS icon
Barclays
BCS
+$4.41M
2
OEC icon
Orion
OEC
+$2.62M
3
KSS icon
Kohl's
KSS
+$1.63M
4
BXC icon
BlueLinx
BXC
+$1.32M
5
EEFT icon
Euronet Worldwide
EEFT
+$1.25M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$4.78M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$1.36M
3
TGLS icon
Tecnoglass
TGLS
+$1.27M
4
SPTN
SpartanNash
SPTN
+$1.16M
5
NWG icon
NatWest
NWG
+$1.07M

Sector Composition

Rank Sector Weight
1 Industrials 20.31%
2 Technology 20.16%
3 Consumer Discretionary 14.5%
4 Materials 11.96%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
51
Ingersoll Rand
IR
$33.1B
$714K 0.65%
16,963
NET icon
52
Cloudflare
NET
$94.3B
$711K 0.64%
16,260
+2,806
+21% +$202K
SJR
53
DELISTED
Shaw Communications Inc.
SJR
$702K 0.63%
+23,828
New +$690K
ALBO
54
DELISTED
Albireo Pharma Inc
ALBO
$695K 0.63%
34,991
-497
-1% -$13.1K
BP icon
55
BP
BP
$109B
$694K 0.63%
146,802
FERG icon
56
Ferguson
FERG
$45.4B
$671K 0.61%
6,000
ICLR icon
57
Icon
ICLR
$13B
$650K 0.59%
3,000
-300
-9% -$67.3K
BABA icon
58
Alibaba
BABA
$276B
$625K 0.57%
5,500
-5,976
-52% -$586K
KALV
59
DELISTED
KalVista Pharmaceuticals
KALV
$609K 0.55%
61,887
+18,157
+42% +$200K
MSGS icon
60
Madison Square Garden
MSGS
$9.57B
$604K 0.55%
4,000
ELF icon
61
e.l.f. Beauty
ELF
$4.95B
$601K 0.54%
19,600
+300
+2% +$7.54K
ALDX icon
62
Aldeyra Therapeutics
ALDX
$95.3M
$596K 0.54%
149,347
+45,305
+44% +$156K
TWTR
63
DELISTED
Twitter, Inc.
TWTR
$595K 0.54%
+15,903
New +$682K
DXPE icon
64
DXP Enterprises
DXPE
$2.57B
$590K 0.53%
19,278
+1,828
+10% +$50.2K
CDRE icon
65
Cadre Holdings
CDRE
$1.4B
$585K 0.53%
29,722
+9,753
+49% +$230K
CNNE icon
66
Cannae Holdings
CNNE
$650M
$585K 0.53%
30,247
+1,737
+6% +$36.4K
OXM icon
67
Oxford Industries
OXM
$602M
$568K 0.51%
+6,400
New +$575K
MGTX icon
68
MeiraGTx Holdings
MGTX
$1.14B
$555K 0.5%
73,363
+45,318
+162% +$440K
VSTO
69
DELISTED
Vista Outdoor Inc.
VSTO
$536K 0.48%
19,206
GPN icon
70
Global Payments
GPN
$23B
$528K 0.48%
+4,776
New +$604K
APO icon
71
Apollo Global Management
APO
$71.6B
$514K 0.46%
10,607
+2,414
+29% +$131K
GOOGL icon
72
Alphabet (Google) Class A
GOOGL
$3.99T
$510K 0.46%
4,680
+60
+1% +$7.06K
MGI
73
DELISTED
MoneyGram International, Inc. New
MGI
$510K 0.46%
+51,016
New +$514K
FLR icon
74
Fluor
FLR
$7.22B
$496K 0.45%
20,360
+6,960
+52% +$187K
AMWD
75
DELISTED
American Woodmark
AMWD
$489K 0.44%
10,873
-8,817
-45% -$426K

Similar funds

Apogem Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Apogem Capital held 213 positions worth $111M, down 24% from $146M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Apogem Capital withdrew a net $4.31M in Q2 2022, closing 62 positions and reducing 31 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $1.36M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Apogem Capital opened a new position in Barclays worth $1.05M.

  • Apogem Capital's largest Q2 2022 buy was Barclays: 561,309 shares worth $1.05M.
  • Apogem Capital added most to Orion in Q2 2022, an estimated $2.62M increase.
  • Apogem Capital's biggest Q2 2022 reduction was Vodafone, cutting an estimated $4.78M.
  • Apogem Capital fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $1.36M.
  • Apogem Capital's ten largest holdings make up 29% of its $111M portfolio in Q2 2022.
  • Apogem Capital opened 40 new positions and closed 62 in Q2 2022.
  • Apogem Capital's portfolio value fell 24% quarter-over-quarter to $111M.

Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.